SEC Filing Details

Form
POS AM
Filing Date
March 1, 2022
Document Date
March 1, 2022
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

Copyright © 2024 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use